Hottest Stories: San Juan Basin Royalty Trust (NYSE:SJT), Five9 (NASDAQ:FIVN), Garmin (NASDAQ:GRMN), Celsion Corp. (NASDAQ:CLSN), CEL-SCI Corporation (NYSEMKT:CVM)

San Juan Basin Royalty Trust (NYSE:SJT) shares moved up 9.34% in last trading session and ended the day at $5.97. SJT has a return on assets of 154.30%. San Juan Basin Royalty Trust (NYSE:SJT) quarterly performance is 33.77%.

Compass Bank, as Trustee of the San Juan Basin Royalty Trust (NYSE:SJT), declared a monthly cash distribution to the holders of its Units of beneficial interest of $182,039.19 or $0.003906 per Unit, based principally upon production during the month of February 2016. The distribution is payable May 13, 2016, to Unit Holders of record as of April 29, 2016.

Five9, Inc. (NASDAQ:FIVN) ended the last trading day at $9.03. Company weekly volatility is calculated as 5.16% and price to cash ratio as 8.22. Five9, Inc. (NASDAQ:FIVN) showed a weekly performance of 7.50%.

Five9, Inc. (NASDAQ:FIVN) announced that it will release financial results for the first quarter ended March 31, 2016 following the close of market on Tuesday, May 10, 2016. The Company will host a corresponding conference call and webcast at 4:30 p.m. Eastern Time on that day.

Garmin Ltd. (NASDAQ:GRMN) invites shareholders and investors to listen to its first quarter 2016 earnings conference call that will be broadcast over the Internet on Wednesday, April 27, 2016 at 10:30 a.m. ET, with executives of Garmin. The call will be held in conjunction with the company’s earnings release, which will be distributed prior to the market opening on April 27, 2016.
On 19 April, Garmin Ltd. (NASDAQ:GRMN) shares moved up 0.78% and was closed at $42.60. GRMN EPS growth in last 5 year was -4.20%. Garmin Ltd. (NASDAQ:GRMN) year to date (YTD) performance is 16.10%.

Celsion Corp. (NASDAQ:CLSN) shares moved up 7.45% in last trading session and ended the day at $1.73. CLSN has a return on assets of -40.30%. Celsion Corp. (NASDAQ:CLSN) quarterly performance is 41.80%.

Celsion Corporation (NASDAQ:CLSN), an oncology drug development company, announced that data highlighting the potential of GEN-1 in ovarian cancer will be presented at the upcoming American Association for Cancer Research (AACR) Annual Meeting, which is being held in New Orleans from April 16-20, 2016.

CEL-SCI Corporation (NYSEMKT:CVM) caters to the Healthcare space. Its weekly performance is -8.21%. On the last day of trading company shares ended up at $0.53. CEL-SCI Corporation (NYSEMKT:CVM) distance from 50-day simple moving average (SMA50) is -3.86%.

CEL-SCI Corporation (NYSE MKT:CVM) announced that its CEO, Geert Kersten, was recently interviewed on The RedChip Money Report television program. The interview air Sunday, April 10, at 11:00 a.m. ET on Newsmax TV, available in 40 million homes via DIRECTV, DISH Network, and Verizon FiOS.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *